Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Zymergen Inc. (ZY : NSDQ)
 
 • Company Description   
Zymergen Inc. is a biofacturing company. It design, develop and manufacture bio-based breakthrough products. Zymergen Inc. is based in EMERYVILLE, Calif.

Number of Employees: 507

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.27 Daily Weekly Monthly
20 Day Moving Average: 1,471,489 shares
Shares Outstanding: 103.14 (millions)
Market Capitalization: $130.99 (millions)
Beta:
52 Week High: $46.05
52 Week Low: $1.20
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.65% -21.88%
12 Week -67.93% -63.96%
Year To Date -81.02% -76.81%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5980 HORTON STREET SUITE 105
-
EMERYVILLE,CA 94608
USA
ph: 415-801-8073
fax: -
investors@zymergen.com http://www.zymergen.com
 
 • General Corporate Information   
Officers
Jay Flatley - Chairman and Acting Chief Executive Officer
Enakshi Singh - Chief Financial Officer
Sandra E. Peterson - Lead Independent Director
Steven Chu - Director
Christine M. Gorjanc - Director

Peer Information
Zymergen Inc. (CSBHY)
Zymergen Inc. (ARWM)
Zymergen Inc. (FUL)
Zymergen Inc. (IAX)
Zymergen Inc. (AVD)
Zymergen Inc. (ASH)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: CHEM-SPECIALTY
Sector: Basic Materials
CUSIP: 98985X100
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
Share - Related Items
Shares Outstanding: 103.14
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $130.99 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.75 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-2.87 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 13.78% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/15/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.38
Price/Cash Flow: -
Price / Sales: 7.36
EPS Growth
vs. Year Ago Period: 89.25%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 28.27%
vs. Previous Quarter: 57.65%
ROE
03/31/22 - -72.62
12/31/21 - -213.99
09/30/21 - -
ROA
03/31/22 - -52.39
12/31/21 - -64.50
09/30/21 - -72.68
Current Ratio
03/31/22 - 4.00
12/31/21 - 5.54
09/30/21 - 4.28
Quick Ratio
03/31/22 - 3.93
12/31/21 - 5.46
09/30/21 - 4.23
Operating Margin
03/31/22 - -1,834.70
12/31/21 - -2,024.89
09/30/21 - -1,746.57
Net Margin
03/31/22 - -1,962.56
12/31/21 - -2,160.81
09/30/21 - -1,831.95
Pre-Tax Margin
03/31/22 - -1,962.46
12/31/21 - -2,160.51
09/30/21 - -1,831.81
Book Value
03/31/22 - 3.34
12/31/21 - 3.99
09/30/21 - 4.66
Inventory Turnover
03/31/22 - 10.09
12/31/21 - 11.68
09/30/21 - 14.24
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©